Skip to main content
OpenTrials

Clinical trial condition

Lupus Nephritis - World Health Organization (WHO) Class III

Explore clinical trials studying Lupus Nephritis - World Health Organization (WHO) Class III. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Lupus Nephritis - World Health Organization (WHO) Class III trial results

Active, Not Recruiting

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

NCT05938725

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Colorado Denver, Colorado, United States
  • University of Massachusetts Worcester Worcester, Massachusetts, United States
  • Northwell Health Great Neck, New York, United States
View Trial Details

Related conditions